Georg A. Funk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Georg A. Funk has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Annette Oxenius
Institute of Microbiology, Wolfgang‐Pauli Strasse, ETH Zurich Hoenggerberg, Zurich
1 shared publicationBeda Joos
Division of Infectious Diseases, Raemistrasse, University Hospital Zurich, Zurich, Switzerland
1 shared publication- Hans Hellmuth Hirsch
Translational Virus Immunity Pathology, Immunology Research, Department of Medical Biology UiT The Arctic University of Norway Tromsø Norway
1 shared publication - Huldrych F. Günthard
Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich , Zurich
1 shared publication Marek Fischer
Division of Infectious Diseases, Raemistrasse, University Hospital Zurich, Zurich, Switzerland
1 shared publicationMarkus Flepp
Division of Infectious Diseases, Raemistrasse, University Hospital Zurich, Zurich, Switzerland
1 shared publication
Latest Publications
- Open Access
- 20 September 2012
- Published by Elsevier in American Journal of Transplantation
- Vol. 12 (11) , 3163-3164
Adaptive Immunity Rather Than Viral Cytopathology Mediates Polyomavirus-Associated Nephropathy in Mice
- 20 September 2012
- Published by Elsevier in American Journal of Transplantation
- Vol. 12 (11) , 3163-3164
Open AccessAdaptive Immunity Rather Than Viral Cytopathology Mediates Polyomavirus-Associated Nephropathy in Mice
- 31 August 2010
- Published by Elsevier in Virus Research
- Vol. 151 (2) , 244-245
Quantitative considerations to gather maximum information from viral growth efficiency studies: The example of polyomavirus type BK (BKV)
- 31 August 2010
- Published by Elsevier in Virus Research
- Vol. 151 (2) , 244-245
Quantitative considerations to gather maximum information from viral growth efficiency studies: The example of polyomavirus type BK (BKV)
- Open Access
- 15 September 2009
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 49 (6) , 989-990
From Plasma BK Viral Load to Allograft Damage: Rule of Thumb for Estimating the Intrarenal Cytopathic Wear
Potential conflicts of interest. G.A.F. and H.H.H.: no conflicts.
- 15 September 2009
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 49 (6) , 989-990
Open AccessFrom Plasma BK Viral Load to Allograft Damage: Rule of Thumb for Estimating the Intrarenal Cytopathic Wear
Potential conflicts of interest. G.A.F. and H.H.H.: no conflicts.
- 17 July 2006
- Published by Wiley in Journal of Medical Virology
- Vol. 78 (9) , 1141-1146
HIV replication elicits little cytopathic effects in vivo: Analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death
Several potential mechanisms for viral destruction of HIV‐infected cells have been described. The hypothesis was examined that if HIV were cytopathic, a positive relation between the in vivo virus production or CTL activity and infected cell death should be observed. In a regression analysis no significant relation was found between surrogate markers for in vivo virus production or the virus‐specific CTL response and death rates of productively infected cells. In a subgroup of patients the hypothesis is rejected that HIV replication elicits a large (R2 > 0.25) cytopathic effect (P < 0.05, N = 36). It is concluded that HIV replication elicits little cytopathic effect in productively infected cells and that CD4+ T lymphocytes are eroded by other mechanisms. J. Med. Virol. 78:1141–1146, 2006.
- 17 July 2006
- Published by Wiley in Journal of Medical Virology
- Vol. 78 (9) , 1141-1146
HIV replication elicits little cytopathic effects in vivo: Analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death
Several potential mechanisms for viral destruction of HIV‐infected cells have been described. The hypothesis was examined that if HIV were cytopathic, a positive relation between the in vivo virus production or CTL activity and infected cell death should be observed. In a regression analysis no significant relation was found between surrogate markers for in vivo virus production or the virus‐specific CTL response and death rates of productively infected cells. In a subgroup of patients the hypothesis is rejected that HIV replication elicits a large (R2 > 0.25) cytopathic effect (P < 0.05, N = 36). It is concluded that HIV replication elicits little cytopathic effect in productively infected cells and that CD4+ T lymphocytes are eroded by other mechanisms. J. Med. Virol. 78:1141–1146, 2006.